Form 4 for NKTX Nkarta, Inc.
Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-05 · accession 0000899243-21-032196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-09 | 2021-08-05 | NKTX | Rajangam Kanya | Chief Medical Off | M - OptEx | $0.41 | +10.0K | 10.0K | New | +$4,100 |
| D | 2021-08-09 | 2021-08-05 | NKTX | Rajangam Kanya | Chief Medical Off | S - Sale+OE | $37.28 | -10.0K | 0 | -100% | -$372.8K |
| D | 2021-08-09 | 2021-08-05 | NKTX | Rajangam Kanya | Chief Medical Off | M - OptEx | $0.00 | -10.0K | 44.1K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | M | A | 10,000 | $0.41 | 10,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-05 | S | D | 10,000 | $37.28 | 0 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $37.02 to $37.63, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-05 | M | D | 10,000 | $0.00 | 44,054 | D | $0.41 · — to 2028-12-06 | 10,000 Common Stock | (F3) The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 3, 2022. |